RP-29307 is an experimental compound being researched for its potential use in the treatment of neurological disorders, particularly Alzheimer's disease. It functions as a selective modulator of the sigma-1 receptor, which plays a role in cellular signaling, neuroprotection, and maintaining neuronal health. By targeting the sigma-1 receptor, RP-29307 may help improve cognitive function and protect neurons from damage associated with neurodegenerative diseases. Its mechanism aims to enhance neuronal resilience and reduce symptoms of Alzheimer's disease, though it is still undergoing clinical investigation.
MedKoo Cat#: 146013
Name: RP-29307
CAS#: 43200-81-3
Chemical Formula: C11H7ClN4O2
Exact Mass: 262.0300
Molecular Weight: 262.65
Elemental Analysis: C, 50.30; H, 2.69; Cl, 13.50; N, 21.33; O, 12.18
The following data is based on the product molecular weight 262.65 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
